SPAMEDICA LTD

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  +0.2%

  £281,110,000 → £281,646,000

• Cash

  -93.6%

  £9,842,000 → £627,000

• Net assets

  +25%

  £201,770,000 → £252,178,000

• Employees

  +19.9%

  1,667 → 1,999

• Operating profit

  -29.1%

  £87,978,000 → £62,358,000

• Profit before tax

  -29.6%

  £87,863,000 → £61,813,000

• Wages

  +19.9%

  £55,455,000 → £66,499,000

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 102

Reporting scope

Standalone (parent only)

Auditor

PricewaterhouseCoopers LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“After considering all the factors the directors have a reasonable expectation the Company has adequate resources to continue in operation and manage the risks for at least the going concern assessment period, which is twelve months from the date of signing of these financial statements. Accordingly, they have decided to adopt the going concern basis in the preparation of the annual financial statements.”

Significant events

• “Since the reporting end date, the Company has completed a number of additional hospitals.”
• “The Company and its immediate holding company, JPTR Bidco Limited, are guarantors of Veonet Group debt facilities, which are repayable by 21 April 2031. At 31 December 2024, these debt facilities comprised €1,059m, £312m and CHF105m; of which €852m, £312m and CHF105m had been utilised. Since the year end, the facilities were increased by €95m.”
• “Since the year end, the Belfast hospital's trade, assets and employees have been transferred to Veonet Northern Ireland Limited with assets being transferred at the carrying net book value on the date of transfer.”
• “In prior years, the Company claimed corporation tax group relief from other UK group entities without paying any consideration. As the surrender of these tax losses (an asset) by UK group entities could be considered a distribution under the Companies Act 2006, it was decided in July 2025 that a payment of £18,011,000, based on the surrendered tax losses and applicable prior period corporation tax rates, was settled through inter-company loan accounts, with a corresponding charge to corporation tax in the statement of comprehensive income.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

2

last 12 months

Capital events

0

last 24 months

Officers appointed

0

last 12 months

Officers resigned

0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.